Vertex (VRTX) EVP/CMO Carmen Bozic Sells Shares

What Happened

• Carmen Bozic, Executive Vice President and Chief Medical Officer at Vertex Pharmaceuticals (VRTX), sold 1,974 shares in an open-market/private sale on May 29, 2026. The shares were disposed at $450.00 per share, for a total transaction value of $888,300. This was a sale (disposition), not a purchase.

Key Details

• Transaction date: 2026-05-29
• Price per share: $450.00; Shares sold: 1,974; Total value: $888,300
• Transaction code: S (Sale)
• Filed with SEC: Form 4 filed 2026-06-02 (timely — within two business days of the transaction)
• Shares owned after transaction: Not specified in the provided filing
• Footnote: Sale was made pursuant to a company-approved Rule 10b5-1 trading plan entered 11/20/2025

Context

• The trade was executed under a 10b5-1 plan, which is a pre-arranged trading schedule that insiders often use to avoid questions about timing; such plans can make it harder to infer the insider’s current view of the company. Sales are often routine and generally less informative than purchases about insider sentiment.